Hilde Berner Hammer
Utdanning
- Cand.med ved det medisinske fakultet, Universitet i Oslo (1982)
- Doktorgrad (PhD) ved det medisinske fakultet, Universitetet i Oslo (1991)
- Spesialist i indremedisin (2001)
- Spesialist i revmatologi (2001)
Stilling
- Overlege, Klinikk for revmatologi, poliklinikk og forskning, Diakonhjemmet sykehus
- Professor II, Institutt for klinisk medisin, Universitetet i Oslo
Interessefelt
- Ultralyd Inflammasjonsmarkører
- Revmatologisk smerte
Annet
- Leder av arbeidspakke 2 i REMEDY (Presisjonsmedisin)
- Æresmedlem Norsk Revmatologisk Forening
E-post
Besøksadresse
Diakonhjemmet sykehus
Forstanderboligen
Reidar Kobros vei 8
0370 Oslo
Postadresse
Diakohjemmet sykehus
Postboks 23 Vinderen
0319 Oslo
Prosjekter
WP1 - Behandlingsstudier
ARCTIC
Remisjon hos pasienter med revmatoid artritt: en randomisert kontrollert studie som undersøker bruk av ultralyd i klinisk oppfølging
Prosjektleder:
Espen A. Haavardsholm
Prosjektleder:
Hilde Berner Hammer
Prosjektleder:
Hilde Berner Hammer
WP1 - Behandlingsstudier
PICASSO
Behandling av smertefull inflammatorisk carpometacarpal-1 osteoartritt med intraartikulære steroider, saltvann eller ergoterapi
Prosjektleder:
Ida K. Bos-Haugen
WP5 - Strategier for digital oppfølging
ReMonit Gout
Digital hjemmeoppfølging og mestring av urinsyregikt
Prosjektleder:
Nina Østerås
WP1 - Behandlingsstudier
SQUEEZE
Maksimering av effekten av reseptbelagte legemidler ved revmatoid artritt
Prosjektleder:
Espen A. Haavardsholm
WP2 - Presisjonsmedisin
ULRABIT
Langsgående ultralydstudie av pasienter med revmatoid artritt som starter behandling med biologiske DMARD-legemidler
Prosjektleder:
Hilde Berner HammerPublikasjoner
Publikasjoner hentet fra Nasjonalt vitenarkiv (NVA):
Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort
Alexandre Sepriano, Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Sarah Ohrndorf, Olivier FitzGerald
Clinical Rheumatology
2024
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts
Helga Westerlind, Bente Glintborg, Hilde Berner Hammer, Saedis Saevarsdottir, Niels Steen Krogh, Merete Lund Hetland
RMD Open
2023
Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods
Hilde Berner Hammer, Sigve Lars Pedersen, Maria Karolina Jonsson, Linda Mathsson-Alm, Isabel Gehring, Joseph Sexton
Scandinavian Journal of Clinical and Laboratory Investigation
2023
The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study
A.F. Podewski, A.M. Glimm, I. Fischer, G.A.W. Bruyn, P. Hanova, Hilde Berner Hammer
Arthritis Research & Therapy
2022
Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study
Hilde Berner Hammer, Silvia Christin Hellerud Rollefstad, Anne Grete Semb, Gro Elisabeth Jensen, Lars Fridtjof Karoliussen, L Terslev
RMD Open
2022
Study protocol for the follow-up examination of the Nor-Hand study: A hospital-based observational cohort study exploring pain and biomarkers in people with hand osteoarthritis
Marthe Gløersen, Pernille Steen Pettersen, Øystein Gunnar Maugesten, Elisabeth Mulrooney, Alexander Mathiessen, Heidi Gammelsrud
Osteoarthritis and Cartilage Open
2021
Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis.
Johanna Elin Gehin, Silje Watterdal Syversen, David Warren, Guro Løvik Goll, Joseph Sexton, Nils Bolstad
RMD Open
2021
Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
Hilde Berner Hammer, Inger Marie Jensen Hansen, Pentti Järvinen, Marjatta Leirisalo-Repo, Michael Ziegelasch, Birte Agular
Rheumatology - Advances in Practice (Rheumap)
2021
Very low prevalence of ultrasound-detected tenosynovial abnormalities in healthy subjects throughout the age range: OMERACT ultrasound minimal disease study
Jeanette Trickey, Ilfita Sahbudin, Mads Ammitzbøll-Danielsen, Irene Azzolin, Carina Borst, Alessandra Bortoluzzi
Annals of the Rheumatic Diseases
2021
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: Achievements of the urate target levels and predictors of obtaining this target
Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tove Borgen, Espen A. Haavardsholm, Tore Kristian Kvien
RMD Open
2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-To-Target strategy
Ulf Gunnar Sundin, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Lena Kristine Bugge Nordberg, Hilde Berner Hammer
RMD Open
2021
Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis
Hilde Berner Hammer, Ib M.J. Hansen, Pentti Järvinen, Marjatta T. Leirisalo-Repo, Michael Ziegelasch, Birte Agular
Scandinavian Journal of Rheumatology
2021
Validity and diagnostic performance of fluorescence optical imaging measuring synovitis in hand osteoarthritis: baseline results from the Nor-Hand cohort
Øystein Gunnar Maugesten, Alexander Mathiessen, Hilde Berner Hammer, Sigrid Valen Hestetun, Tore Kristian Kvien, Till Uhlig
Arthritis Research & Therapy
2020
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Hilde Berner Hammer, Lars Fridtjof Karoliussen, Lene Terslev, Espen A Haavardsholm, Tore Kristian Kvien, Till Uhlig
Annals of the Rheumatic Diseases
2020
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis
Hilde Berner Hammer, Brigitte Michelsen, Joe Sexton, Till Uhlig, Sella Aarrestad Provan
Clinical Rheumatology
2020
Associations Between Ultrasound-Detected Synovitis, Pain and Function in Interphalangeal and Thumb Base Osteoarthritis: Data From the Nor-Hand Study
Caroline Mehl Fjellstad, Alexander Mathiessen, Barbara Therese Slatkovsky Christensen, Tore Kristian Kvien, Hilde Berner Hammer, Ida Kristin Bos-Haugen
Arthritis care & research
2019
Assessing synovitis in the hands in patients with rheumatoid arthritis by ultrasound: an agreement study exploring the most inflammatory active side from two Norwegian trials
Lene Terslev, Robin Christensen, Anna-Birgitte Aga, Joseph Sexton, Espen A. Haavardsholm, Hilde Berner Hammer
Arthritis Research & Therapy
2019
Swollen, but not tender joints, are independently associated with ultrasound synovitis: Results from a longitudinal observational study of patients with established rheumatoid arthritis
Hilde Berner Hammer, Brigitte Michelsen, Joseph Sexton, Ida Kristin Haugen, Sella Aarrestad Provan, Espen A. Haavardsholm
Annals of the Rheumatic Diseases
2019
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
Lena Kristine Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Elisabeth Lie
RMD Open
2018
DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs
Silva Pukšić, Pernille Bolton-King, Joseph Sexton, Brigitte Michelsen, Tore Kristian Kvien, Hilde Berner Hammer
RMD Open
2018
The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: Secondary analyses from a randomized trial examining the benefit of ultrasound in a clinical tight control regimen
Lena Kristine Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Elisabeth Lie, Hilde Berner Hammer
Arthritis & Rheumatology
2018
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: Associations to future good radiographic and physical outcomes
Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Inge Christoffer Olsen, Hilde Berner Hammer, Till Uhlig, Desirée van der Heijde
Annals of the Rheumatic Diseases
2018
Health-related quality of life in patients with psoriatic and rheumatoid arthritis: Data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls
Brigitte Michelsen, Till Uhlig, Joseph Sexton, Desirée van der Heijde, Hilde Berner Hammer, Eirik Kristianslund
Annals of the Rheumatic Diseases
2018
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study
Brigitte Michelsen, Eirik Kristianslund, Joseph Sexton, Hilde Berner Hammer, Karen Minde Fagerli, Elisabeth Lie
Annals of the Rheumatic Diseases
2017